OICR News / Tag

OICR Leadership

Browse news tagged OICR Leadership.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

Talent

Ontario Institute for Cancer Research welcomes Dr. Aaron Schimmer as President and Scientific Director

Schimmer brings extensive experience as scientist, clinician and research leader. Toronto, ON, August 4, 2026 — Dr. Aaron Schimmer officially steps into his role as President and Scientific Director of the Ontario Institute for Cancer…

ArticleAug 04, 2026

Talent

OICR appoints Dr. Steven Gallinger as Head, Clinical Translation

Gallinger brings more than three decades of clinical and interdisciplinary research experience to OICR leadership Dr. Steven Gallinger has joined OICR’s executive leadership team as Head, Clinical Translation. In this role, he will lead one…

ArticleMar 18, 2021

Talent

Dr. Rima Al-awar promoted to Head of Therapeutic Innovation and Drug Discovery at OICR

Al-awar joins OICR’s executive team with plans to expand drug discovery and development initiatives across Ontario Dr. Rima Al-awar has joined OICR’s executive team as Head, Therapeutic Innovation and Drug Discovery. In this role, she…

ArticleNov 01, 2019

Talent

Q&A with Dr. Trevor Pugh, OICR’s new Director of Genomics

Dr. Trevor Pugh In May, OICR welcomed Dr. Trevor Pugh as Director of Genomics and Senior Principal Investigator. Trevor is a cancer genomics researcher and board-certified molecular geneticist who has led the Princess Margaret Cancer…

ArticleMay 31, 2019

TalentBreast cancer

New OICR President and Scientific Director comments on breakthrough in breast cancer T-cell immunotherapy

For the first time, a patient’s late-stage breast cancer has been successfully treated with T-cell immunotherapy. This cutting-edge approach, which is currently in clinical trials in the U.S., modified the patient’s naturally-occurring immune cells to…

ArticleJun 14, 2018

Commercialization

FACIT Appoints Biotech Veteran Dr. David O’Neill as President

Entrepreneur adds US oncology management experience to Ontario commercialization TORONTO, ON (June 13, 2018) -- The Board of Trustees announced the appointment of David O’Neill as the President of FACIT. Dr O’Neill joined FACIT in 2013…

ArticleJun 13, 2018

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

OICR Leadership

Discover the latest news and insightsDiscover the latest news and insights

Tagged stories

Ontario Institute for Cancer Research welcomes Dr. Aaron Schimmer as President and Scientific Director

OICR appoints Dr. Steven Gallinger as Head, Clinical Translation

Dr. Rima Al-awar promoted to Head of Therapeutic Innovation and Drug Discovery at OICR

Cancer solved together — in your inbox

Q&A with Dr. Trevor Pugh, OICR’s new Director of Genomics

New OICR President and Scientific Director comments on breakthrough in breast cancer T-cell immunotherapy

FACIT Appoints Biotech Veteran Dr. David O’Neill as President